Yang, C
The best evidence available is that BPC-157 results in improved outcomes in muscle, tendon, ligament, and bone injury models in animals. There are probably trials ongoing, but if we are being honest about the totality of evidence available to us right now , it is irresponsible to claim either way that BPC-157 does or does not increase performance
That conclusion turned out to be incomplete
Handle only in a controlled laboratory setting
TB4 was confirmed to drive mobilisation, migration, and differentiation of stem and progenitor cells for tissue repair and new vessel formation, while also decreasing myofibroblast numbers in wounds resulting in reduced scar formation and fibrosis
The initial visit includes intake, baseline bloodwork as clinically indicated, an honest discussion of evidence quality and realistic expectations, and protocol design based on individual goals and clinical profile